CN1351610A - 晶体棘白菌素铵盐的生成和阴离子交换 - Google Patents

晶体棘白菌素铵盐的生成和阴离子交换 Download PDF

Info

Publication number
CN1351610A
CN1351610A CN00804419A CN00804419A CN1351610A CN 1351610 A CN1351610 A CN 1351610A CN 00804419 A CN00804419 A CN 00804419A CN 00804419 A CN00804419 A CN 00804419A CN 1351610 A CN1351610 A CN 1351610A
Authority
CN
China
Prior art keywords
salt
echinocandin
concentrate
crystalline
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00804419A
Other languages
English (en)
Chinese (zh)
Inventor
B·W·达德勒
M·A·道特里啻
N·J·卡尔曼
S·D·拉森
S·范顿比尔赫斯诺里克
J·T·维森兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN1351610A publication Critical patent/CN1351610A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/84Manufacture, treatment, or detection of nanostructure
    • Y10S977/895Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
    • Y10S977/896Chemical synthesis, e.g. chemical bonding or breaking
    • Y10S977/898Enzymatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN00804419A 1999-03-03 2000-03-02 晶体棘白菌素铵盐的生成和阴离子交换 Pending CN1351610A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12307399P 1999-03-03 1999-03-03
US60/123,073 1999-03-03

Publications (1)

Publication Number Publication Date
CN1351610A true CN1351610A (zh) 2002-05-29

Family

ID=22406562

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00804419A Pending CN1351610A (zh) 1999-03-03 2000-03-02 晶体棘白菌素铵盐的生成和阴离子交换

Country Status (18)

Country Link
US (1) US6590073B2 (enExample)
EP (1) EP1155034B1 (enExample)
JP (1) JP4063497B2 (enExample)
KR (1) KR20020002476A (enExample)
CN (1) CN1351610A (enExample)
AT (1) ATE338060T1 (enExample)
AU (1) AU767956B2 (enExample)
BR (1) BR0009248A (enExample)
CA (1) CA2362826A1 (enExample)
CY (1) CY1105777T1 (enExample)
DE (1) DE60030415T2 (enExample)
DK (1) DK1155034T3 (enExample)
ES (1) ES2270819T3 (enExample)
HK (1) HK1040087A1 (enExample)
IL (1) IL145186A0 (enExample)
PT (1) PT1155034E (enExample)
WO (1) WO2000052036A1 (enExample)
ZA (1) ZA200107999B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102485879A (zh) * 2010-12-03 2012-06-06 上海医药工业研究院 一种用于生产wf11899a的发酵培养基
CN105669840A (zh) * 2014-12-05 2016-06-15 重庆乾泰生物医药有限公司 一种高纯度棘白菌素b母核盐酸盐的晶体及其制备方法
CN110128507A (zh) * 2014-12-05 2019-08-16 重庆乾泰生物医药有限公司 一种棘白菌素b母核或其盐的水合物及制备方法和用途

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
CN1337968A (zh) 1998-12-09 2002-02-27 伊莱利利公司 蓝刺菌素环肽化合物的纯化
DK1155034T3 (da) 1999-03-03 2007-01-08 Lilly Co Eli Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ecb処方物および組成物の作製方法
CN100335122C (zh) * 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂
KR20020003864A (ko) 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
WO2010108637A1 (en) * 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN102464704B (zh) * 2010-11-05 2013-12-11 上海医药工业研究院 一种化合物及其制备方法和用途
CN102295686A (zh) * 2011-09-09 2011-12-28 杭州华东医药集团生物工程研究所有限公司 一种纽莫康定b0的提取纯化方法
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) * 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
US12060439B2 (en) 2018-10-25 2024-08-13 Napp Pharmaceutical Group Limited Polymorph of echinocandin antifungal agent

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293482A (en) 1962-06-21 1966-12-20 Rca Corp Plural output traveling wave tube
JPS5134916B2 (enExample) 1974-03-06 1976-09-29
US4299763A (en) 1979-12-13 1981-11-10 Eli Lilly And Company A-30912B Nucleus
US4293489A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
CA1170598A (en) * 1979-12-13 1984-07-10 Bernard J. Abbott Process for the preparation of cyclic peptide nuclei
US4293482A (en) 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4320052A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293483A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4304716A (en) 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4876241A (en) 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DK173802B1 (da) 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
CA2037957A1 (en) 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5310726A (en) 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
EP0460882B1 (en) 1990-06-07 1996-07-24 Eli Lilly And Company Lipopeptide deacylase
FI912873L (fi) 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
US5198421A (en) 1991-04-26 1993-03-30 Merck & Co., Inc. Phosphorylated cyclic lipopeptide
IL105048A (en) 1992-03-19 2001-06-14 Eli Lilly And Company U S Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5646111A (en) 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5652213A (en) 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
JP2001503015A (ja) * 1996-02-01 2001-03-06 イーライ・リリー・アンド・カンパニー 環状ペプチド抗真菌剤
JPH1036284A (ja) * 1996-07-24 1998-02-10 Sumitomo Pharmaceut Co Ltd プロテアソーム阻害剤
AU8687798A (en) 1997-08-04 1999-02-22 Eli Lilly And Company Cyclic peptide antifungal agents
US6232290B1 (en) * 1998-02-09 2001-05-15 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides with antimicrobial activity
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (en) 1998-08-20 2005-01-26 Eli Lilly & Company Synthesis of ring-modified cyclic peptide analogs
ATE267210T1 (de) 1998-08-28 2004-06-15 Lilly Co Eli Reversible borkomplexe von 1,2-(cis)-diol zyklischen peptiden
CN1337968A (zh) 1998-12-09 2002-02-27 伊莱利利公司 蓝刺菌素环肽化合物的纯化
JP2002535248A (ja) 1998-12-16 2002-10-22 イーライ リリー アンド カンパニー 環式ペプチド抗真菌剤
CA2354055A1 (en) 1998-12-16 2000-06-22 Eli Lilly And Company Cyclic peptide antifungal agents having a sugar substituent
DK1155034T3 (da) 1999-03-03 2007-01-08 Lilly Co Eli Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte
KR20020003864A (ko) 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ecb処方物および組成物の作製方法
CN100335122C (zh) 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102485879A (zh) * 2010-12-03 2012-06-06 上海医药工业研究院 一种用于生产wf11899a的发酵培养基
CN105669840A (zh) * 2014-12-05 2016-06-15 重庆乾泰生物医药有限公司 一种高纯度棘白菌素b母核盐酸盐的晶体及其制备方法
CN105669840B (zh) * 2014-12-05 2019-06-04 重庆乾泰生物医药有限公司 一种高纯度棘白菌素b母核盐酸盐的晶体及其制备方法
CN110128507A (zh) * 2014-12-05 2019-08-16 重庆乾泰生物医药有限公司 一种棘白菌素b母核或其盐的水合物及制备方法和用途

Also Published As

Publication number Publication date
HK1040087A1 (zh) 2002-05-24
KR20020002476A (ko) 2002-01-09
DE60030415T2 (de) 2007-08-30
CA2362826A1 (en) 2000-09-08
US20020161176A1 (en) 2002-10-31
DK1155034T3 (da) 2007-01-08
JP4063497B2 (ja) 2008-03-19
WO2000052036A1 (en) 2000-09-08
BR0009248A (pt) 2001-11-20
JP2002538165A (ja) 2002-11-12
ES2270819T3 (es) 2007-04-16
ZA200107999B (en) 2003-06-25
ATE338060T1 (de) 2006-09-15
US6590073B2 (en) 2003-07-08
AU3718200A (en) 2000-09-21
EP1155034A1 (en) 2001-11-21
CY1105777T1 (el) 2011-02-02
AU767956B2 (en) 2003-11-27
DE60030415D1 (de) 2006-10-12
IL145186A0 (en) 2002-06-30
EP1155034B1 (en) 2006-08-30
WO2000052036A8 (en) 2001-06-21
PT1155034E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
CN1351610A (zh) 晶体棘白菌素铵盐的生成和阴离子交换
AU766091B2 (en) Purification of echinocandin cyclopeptide compounds
KR860000343B1 (ko) 클라불란산 및 약제학적으로 허용되는 그의 염을 제조하는 방법
CN105849118B (zh) 大环hcv ns3抑制三肽的合成
WO2011130615A2 (en) Preparation of lacosamide
EP2559696B1 (en) Purification method of azacyclohexapeptide or its salt
CN1050843C (zh) 头孢菌素异构体的分离
CN101475580B (zh) 一种头孢孟多酯钠的合成方法
US8927707B2 (en) Purification method of aztreonam
WO2017059040A1 (en) Processes for the preparation of apremilast and intermediates thereof
CN1222528C (zh) 提纯克拉布兰酸盐的方法
CN1902166A (zh) 高化学纯度r-5-(2-(2-(2-乙氧基苯氧基乙基氨基)丙基)-2-甲氧基苯磺酰胺盐酸盐的制备
CN1184814A (zh) 头孢烯化合物的生产方法
GB2441328A (en) A method for obtaining mupirocin calcium
JP2013509366A (ja) 2−アミノ−3−メチル−ヘキサ−5エン酸、及びバシトラシン等のペプチドの生成におけるその使用方法
AU2004200741A1 (en) Formation and anion-exchange of crystalline echinocandin ammonium salts
JPS58172399A (ja) ムラミルトリペプチド誘導体
AU2004200026A1 (en) Purification of echinocandin cyclopeptide compounds
JP2003515579A (ja) 高純度デフェロキサミン・メシレート塩の製造のための多段階プロセス
JPH01316350A (ja) 抗生物質tan―950、その製造法および用途

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication